Nagase (8012) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
4 Aug, 2026Executive summary
Achieved record-high net sales and profits for Q1 FY2026, with net sales rising 17.9% to ¥279,718 million and gross profit up 24.4% to ¥55,154 million, driven by strong performance in Materials, Electronics, and Life Sciences segments.
Operating income surged 65.9% to ¥17,008 million, and profit attributable to owners of the parent nearly doubled to ¥14,655 million.
Comprehensive income for the quarter reached ¥27,685 million, a significant increase from ¥1,768 million a year earlier.
Gross profit margin improved by 1.0 ppt and operating income ratio by 1.8 ppt year-over-year.
Financial highlights
Earnings per share for Q1 FY2026 were ¥35.93, up from ¥17.40 year-over-year (adjusted for stock split).
Total assets increased to ¥942,118 million as of June 30, 2026, from ¥871,526 million at March 31, 2026.
Net assets rose to ¥456,064 million, with a shareholders' equity ratio of 47.4%.
Operating cash flow was negative ¥21.2 billion due to increased working capital; free cash flow negative ¥25.3 billion.
Foreign exchange gains contributed ¥2.5 billion to gross profit and ¥0.9 billion to operating income.
Outlook and guidance
Full-year FY2027 forecast: net sales ¥1,000,000 million (+2.8% YoY), operating income ¥45,000 million (+0.6%), profit attributable to owners of the parent ¥34,500 million (+4.2%), EPS ¥84.59.
Segment forecasts: Materials sales ¥495.5 billion, Electronics ¥175.0 billion, Life Sciences ¥329.4 billion.
No revisions to the latest consolidated earnings forecast; guidance to be reassessed at Q2 due to Middle East uncertainties and market trends.
Latest events from Nagase
- Record-high profits and sales, with continued growth and margin gains projected.8012
Q4 20267 May 2026 - Record-high profits and margins in 2Q FY2024, led by strong semiconductor and materials demand.8012
Q2 202520 Mar 2026 - Record Q1 profit and margin growth driven by semiconductors, autos, and Functional Materials.8012
Q1 202520 Mar 2026 - Record-high profits and margins from semiconductors and electronics; guidance unchanged.8012
Q3 202520 Mar 2026 - Record profits and higher dividends, with further growth forecast for the next fiscal year.8012
Q4 202520 Mar 2026 - Gross profit margin rose and full-year guidance was raised, but profit declined year-over-year.8012
Q2 202620 Mar 2026 - Record profits and a sharp net profit rise are forecast, led by semiconductors and food ingredients.8012
Q1 202620 Mar 2026 - Record-high profits and sales with strong growth in Life & Healthcare and higher dividends ahead.8012
Q3 202620 Mar 2026